PROGRAMME MILESTONES Sample Clauses

PROGRAMME MILESTONES. The following Xxxxx chart illustrates the key deliverables and the delivery milestones (e.g. DM1) for the GDE FF programme at GHNT, broken down into its component work streams and individual projects. In addition, key deliverables have been matched against funding payment milestones. The anticipated start date of this programme is planned for December 2017. All dates in this proposal are subject to change based on this programme initiation. This is also subject to funding and resource allocation. Any critical dependencies on the GDE will be factored into the programme once the individual detail on the projects has been worked through. A1 Funding Agreement Sign Off Nov-17 Jan-18 A2 Delivery Approach and Framework Feb-18 May-18 A3 Programme mobilisation approach Feb-18 May-18 A4 System Topology Mar-18 Jun-18 B1 Accelerating Patient Flow Feb-18 Dec-18 B2 Live Hospital Management Feb-18 Dec-18 B3 Real time Patient Monitoring Feb-18 Dec-18 B4 Delivering a 24x7 service Apr-18 Jul-19 B5 Clinical Images available anywhere Feb-18 B6 B7 B8 B9 Clinician access to all Images across XxXX and GHNT Digitising Medical Devices Improved Clinical and Operational Decision Making Enabling the Agile Clinician Oct-18 Oct-18 Sep-18 Sep-18 Xxx-00 Xxx-00 Xxx-00 Mar-20 C1 Clinical Records available anywhere Feb-18 Oct-18 C2 Clinical Pathway Workflow Transformation Oct-18 Jan-19 C3 Standardisation of Clinical Records Mar-19 Aug-19 C4 Electronic Medicines Management Apr-18 Aug-19 C5 Closed Loop Medicines Jun-19 Sep-20 C6 Paperless Orders and Results Trust wide Apr-18 Mar-20 C7 C8 C9 C10 C11 Hospital at Night Visible Patient Management - Tasks Visible Patient Management - Referrals Patient Self Care and Management Patient Self Check in Feb-18 Sep-18 Jan-19 May-18 Apr-19 Sep-19 Dec-19 Mar-20 Sep-19 Mar-20 D1 Single Clinician Portal Jun-18 Jun-20 D2 Paperless Outpatients Apr-18 Oct-18 D3 Paperless Nursing Apr-18 Jul-19 D4 Paperless Community Services Apr-18 Oct-18 D5 Paperless AHPs Apr-18 Dec-19 D6 Paperless Clinicians Apr-18 Mar-20 D7 D8 D9 Paperless Mental Health Paperless Theatres Real time NHS Numbers Apr-18 Oct-18 Dec-18 Mar-19 Jun-19 Jun-20 D10 Improving Patient Outcomes Xxx-00 Xxx-00 The attached delivery milestones document provides a summary of each project with an estimated delivery date for the related delivery milestones. In addition, each project is categorised according to the DMA classification contribution.
Sample 1
AutoNDA by SimpleDocs
PROGRAMME MILESTONES. 3.1 There are several Phases of the PROGRAMME: − Phase 1: Entrance to AAPA leading up to PPL; − Phase 2: After PPL leading up to and including CPL and CIR; − Phase 3: Employment with Rex and entrance to Rex Ground School leading up to and including type endorsement; − Phase 4: Employment with Rex as a First Officer; − Phase 5: Entrance into the PICUS programme after meeting all prerequisites and leading up to graduation from PICUS. Cadets who, at the sole discretion of Rex, have poor aptitude either in performance or attitude will not be offered a place in PICUS and will remain at Phase 4 for the rest of the PROGRAMME; − Phase 6: Entrance into the Command Upgrade leading to graduation as Captain. The above represents the principal progression path of the Cadet. However Rex reserves the right to modify the progression from Phase 3 onwards according to the needs of the Rex Group and the performance and attitude of the Cadets while being mindful of the aspirations of the Cadet. 3.2 The Cadet confirms and acknowledges that it is a fundamental element of the PROGRAMME that the Cadet, at his own cost and time, passes the ATPL Air Law and Airline Human Factors exams within 1.5 years of graduating from the Course. The Cadet is required to hold valid credits in all of the ATPL subjects within 2.5 years of graduating from the Course. 3.3 In addition to the terms of clause 3.1, the Cadet acknowledges and accepts that the − continuation in a Phase; and − the graduation from a Phase; and − the entry into the next Phase are all conditional on the Cadet meeting fully at all times Rex's very high expectations of conduct, attitude and performance with high emphasis being placed on conduct and attitude. The Cadet acknowledges and accepts Rex's absolute discretion in this matter. The Cadet should be aware that graduation from a Phase does not automatically entail suitability to enter the next Phase.
Sample 1
PROGRAMME MILESTONES. 4.1 The following milestone dates are provided for information purposes and will be driven by compliance with the Landlord’s, the Tenant’s and the Contractor’s obligations under the Agreement for Lease and the Management Contract. 4.2 Please refer to the MAC-lnteriors Landlord Remodeling Works Construction Programme included at Appendix D for more details on the sequencing of the activities to achieve the following milestone dates. Please note that these dates are now superseded as they were dependent on the date for signing the
Sample 1
PROGRAMME MILESTONES. 3.1 There are several Phases of the PROGRAMME: - Phase 1: entrance to AAPA leading up to PPL; - Phase 2: after PPL leading up to CPL and CIR; - Phase 3: employment with Rex and entrance to Rex Ground School leading up to type endorsement; - Phase 4: employment with Rex as a First Officer; - Phase 5: entrance into the PICUS programme after meeting all prerequisites and leading up to graduation from PICUS; - Phase 6: entrance into the Command Upgrade leading to graduation as Captain. The above represents the principal progression path of the Cadet. However Rex reserves the right to modify the progression from Phase 3 onwards according to the needs of the Xxx Group while being mindful of the aspirations of the Cadet, 3.2 The Cadet confirms and acknowledges that it is a fundamental element of the PROGRAMME that the Cadet, at his own cost and time, passes the ATPL Air Law and Airline Human Factors exams within 1.5 years of graduating from the Course and the remainder of the ATPL subjects within 2.5 years of graduating from the Course. 3.3 The Cadet acknowledges and accepts that the - continuation in a Phase; and - the graduation from a Phase; and - the entry into the next Phase are all conditional on the Cadet meeting fully at all times Rex's very high expectations of conduct, attitude and performance with high weightage being placed on conduct and attitude. The Cadet acknowledges and accepts Rex's absolute discretion in this matter. The Cadet should be aware that graduation from a Phase does not automatically entail suitability to enter the next Phase.
Sample 1
PROGRAMME MILESTONES. Freezing of main machine parameters Completed
Sample 1

Related to PROGRAMME MILESTONES

  • Project/Milestones Taxpayer provides refrigerated warehousing and logistic distribution services to clients throughout the United States. In consideration for the Credit, Taxpayer agrees to invest in a new refrigeration and distribution facility in the XxXxxxxxx Park area of Sacramento, California, and hire full-time employees (collectively, the “Project”). Further, Taxpayer agrees to satisfy the milestones as described in Exhibit A (“Milestones”) and must maintain Milestones for a minimum of three (3) taxable years thereafter. In the event Taxpayer employs more than the number of full-time employees, determined on an annual full-time equivalent basis, than required in Exhibit A, for purposes of satisfying the “Minimum Annual Salary of California Full-time Employees Hired” and the “Cumulative Average Annual Salary of California Full-time Employees Hired,” Taxpayer may use the salaries of any of the full-time employees hired within the required time period. For purposes of calculating the “Minimum Annual Salary of California Full-time Employees Hired” and the “Cumulative Average Annual Salary of California Full-time Employees Hired,” the salary of any full-time employee that is not employed by Taxpayer for the entire taxable year shall be annualized. In addition, the salary of any full-time employee hired to fill a vacated position in which a full-time employee was employed during Taxpayer’s Base Year shall be disregarded.

  • Development Milestones In addition to its obligations under Paragraph 7.1, LICENSEE specifically commits to achieving (either itself or through the acts of a SUBLICENSEE) the following development milestones in its diligence activities under this AGREEMENT: (a) (b).

  • Commercial Milestones (a) Within [*****] calendar days after the end of the first Calendar Year in which aggregate annual Net Sales for that Calendar Year for the Licensed Product in the Territory reach any threshold indicated in the Commercial Milestone Events listed below, EverInsight shall notify VistaGen of the achievement of such Commercial Milestone Event and VistaGen shall invoice EverInsight for the corresponding non-refundable, non-creditable Milestone Payment set forth below and EverInsight shall remit payment to VistaGen within [*****] Business Days after the receipt of the invoice, as described in Section 8.6 (Currency; Exchange Rate; Payments). Annual Net Sales Milestones for Licensed Product Milestone Payments (in Dollars) (each a “Commercial Milestone Event”): (1). [*****] (2). [*****] (3). [*****] (4). [*****] (5). [*****] (b) For the purposes of determining whether a Net Sales Milestone Event has been achieved, Net Sales of Licensed Product(s) in the Territory shall be aggregated. For clarity, the annual Net Sales Milestone Payments set forth in this Section 8.3 (Commercial Milestones) shall be payable only once, upon the first achievement of the applicable Commercial Milestone Event, regardless of how many times such Commercial Milestone Event is achieved. (c) If a Commercial Milestone Event in Section 8.3 (Commercial Milestones) is achieved and payment with respect to any previous Commercial Milestone Event in Section 8.3 has not been made, then such previous Commercial Milestone Event shall be deemed achieved and EverInsight shall notify VistaGen within fifteen (15) calendar days of such achievement. VistaGen shall then invoice EverInsight for such unpaid previous Commercial Milestone Event(s) and EverInsight shall pay VistaGen such unpaid previous milestone payment(s) within thirty (30) Business Days of receipt of such invoice. (d) In the event that, VistaGen believes any Commercial Milestone Event under Section 8.3(a) has occurred but EverInsight has not given VistaGen the notice of the achievement of such Commercial Milestone Event, it shall so notify EverInsight in writing and shall provide to EverInsight data, documentation or other information that supports its belief. Any dispute under this Section 8.3(d) (Commercial Milestones - subsection (d)) that relates to whether or not a Commercial Milestone Event has occurred shall be referred to the JSC to be resolved in accordance with ARTICLE 3 (Governance) and shall be subject to resolution in accordance with Section 14.10 (Dispute Resolution). The Milestone Payments made for each Commercial Milestone Event shall be non-creditable and non-refundable.

  • Milestones Subject to the provisions of the SGIP, the Parties shall agree on milestones for which each Party is responsible and list them in Attachment 4 of this Agreement. A Party’s obligations under this provision may be extended by agreement. If a Party anticipates that it will be unable to meet a milestone for any reason other than a Force Majeure event, it shall immediately notify the other Parties of the reason(s) for not meeting the milestone and (1) propose the earliest reasonable alternate date by which it can attain this and future milestones, and (2) requesting appropriate amendments to Attachment 4. The Party affected by the failure to meet a milestone shall not unreasonably withhold agreement to such an amendment unless it will suffer significant uncompensated economic or operational harm from the delay, (1) attainment of the same milestone has previously been delayed, or (2) it has reason to believe that the delay in meeting the milestone is intentional or unwarranted notwithstanding the circumstances explained by the Party proposing the amendment.

  • Sales Milestones (a) As to each Therapeutic Product, SANOFI-AVENTIS shall pay MERRIMACK up to a total of Sixty Million Dollars (US$60,000,000) upon the first achievement of the following Net Sales milestones, on a Therapeutic Product-by-Therapeutic Product basis: (i) Total Worldwide Net Sales for such Therapeutic Product exceed $[**] in any four (4) consecutive calendar quarters $ [**] (ii) Total Worldwide Net Sales for such Therapeutic Product exceed $[**] in any four (4) consecutive calendar quarters $ [**] (iii) Total Worldwide Net Sales for Therapeutic Product exceed $[**] in any four (4) consecutive calendar quarters $ [**] (b) Each milestone payment set forth in Section 8.4(a) shall be payable by SANOFI-AVENTIS upon the achievement of the related milestone event by SANOFI-AVENTIS and its Affiliates or sublicensees, and SANOFI-AVENTIS shall provide notice to MERRIMACK promptly upon achievement of such milestone event. SANOFI-AVENTIS shall pay MERRIMACK each such milestone payment within [**] days of such achievement of the related milestone event. (c) For purposes of clarity, more than one of the Net Sales milestones set forth above may be earned in the same four (4) consecutive calendar quarter period with respect to a Therapeutic Product. For example, if total worldwide Net Sales with respect to a given Therapeutic Product have not achieved any of the lower sales milestone thresholds set forth in clause (i) or (ii) of Section 8.3(a) above in any previous four (4) consecutive calendar quarter period, but total worldwide Net Sales with respect to such Therapeutic Product exceed $[**] in a subsequent four (4) consecutive calendar quarter period, then all three milestone payments, totaling $60 Million, payable upon achievement of the sales milestone thresholds set forth in clause (i), (ii) and (iii) of Section 8.3(a) above shall become payable to MERRIMACK hereunder.

  • Targets and Milestones You may choose to develop specific additional targets and milestones which assess your performance in ITT over time – particularly if ITT trainees make up a significant proportion of your overall student body. Alternatively, you may have targets and milestones in your existing 2012-13 access agreement which you now also wish to apply to undergraduate and/or postgraduate ITT trainees. These targets may be statistical – based on how representative your entrants are and/or your retention performance – and might include annual or interim milestones to help you monitor whether you are making progress. You may wish to include criteria around the numbers of trainees in receipt of a full or partial maintenance grant, as financial data will need to be collected to determine bursary support and the data will also be accessible through the Student Loans Company for HEBSS subscribers. You may also wish to consider the TDA guidance at Annex C which gives information on specific groups that are underrepresented in the teaching profession.

  • Milestone A principal event specified in the Contract Documents including the Material Completion and Occupancy Date and other events relating to an intermediate completion date or time.

  • Milestone Schedule Please state the status and progress of each Milestone and identify any completed Milestone(s) for the previous calendar quarter.

  • Milestone Event Milestone Payment [***] [***]

  • Development Milestone Payments (i) In addition to the Closing Date Merger Consideration (less the Remaining Option Consideration and Rights Proceeds Amount, if any) and any Net TNF Sales Payments (as defined below), upon the attainment of the development ** Portions of the Exhibit have been omitted and have been filed separately pursuant to an application for confidential treatment filed with the Securities and Exchange Commission pursuant to Rule 24b-2 under the Securities Exchange Act of 1934, as amended. milestones set forth below (each, a “Development Milestone”), Parent shall, or shall cause the Surviving Corporation to, [**] after the occurrence of each Development Milestone, deliver to the Paying Agent (for further payment to the holders of Stock Certificates and Stock Agreements outstanding immediately prior to the Effective Time), via wire transfer of immediately available funds, the respective amounts set forth below minus, in each case, the applicable Contingent Consideration Distribution Fee associated therewith and any amount designated by the Stockholders’ Representatives to be placed in the Administrative Expense Account (each, a “Development Milestone Payment” and collectively, the “Development Milestone Payments”): (A) Upon FDA approval of Reslizumab for the treatment of eosinophilic esophagitis, a cash payment of [**]; (B) Upon marketing authorization of Reslizumab for the treatment of eosinophilic esophagitis being granted by the European Commission in accordance with Regulation (EC) No. 726/2004, a cash payment of [**]; (C) If Res 5-0010 Asthma Study Completion has not occurred on or prior to the Closing Date, then upon the occurrence of the Res 5-0010 Asthma Study Completion, a cash payment of $50,000,000 (fifty million dollars) (the “Res 5-0010 Asthma Payment”); (D) Upon FDA approval of Reslizumab for any asthma indication, a cash payment of [**]; (E) Upon marketing authorization of Reslizumab for the treatment of any asthma indication being granted by the European Commission in accordance with Regulation (EC) No. 726/2004, a cash payment of [**]; and (F) Upon FDA approval of an Oral Anti-TNF Product, a cash payment of [**].

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!